Living with Ataxia
BioBlast Pharma Announces Positive in vivo Preclinical Proof-of-Concept Results of Its Cabaletta Platform in Spinocerebellar Ataxia Type 3 (SCA3)
General
ataxiabr
November 3, 2016, 3:04pm
3
show post in topic
Related topics
Topic
Replies
Views
Activity
PRODUCT CANDIDATES via BioBlast
General
3
1900
November 4, 2015
Sca3
General
10
2250
September 25, 2012
Clinical trials
General
1
1723
September 4, 2015
New clinical trial for SCA3
General
1
159
May 3, 2022
Troriluzole..optimism re SCA3
General
0
179
May 24, 2022